Loading...
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
OBJECTIVE: Fenfluramine, which was previously approved as a weight loss drug, was withdrawn in 1997 when reports of cardiac valvulopathy emerged. The present study was conducted in part to characterize the cardiovascular safety profile of low‐dose fenfluramine when used in a pediatric population to...
Na minha lista:
| Udgivet i: | Epilepsia |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754414/ https://ncbi.nlm.nih.gov/pubmed/32809271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16638 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|